EU approves Kimberly-Clark's acquisition of Kenvue, subject to conditions

By Reuters News

- The European Commission on Tuesday approved Kimberly-Clark KMB.O's acquisition of Tylenol maker Kenvue KVUE.N after the maker of Kleenex tissues and Huggies diapers offered concessions to address EU antitrust concerns.

Kimberly-Clark offered to sell all its tampon and other feminine hygiene brands in the European Economic Area, the Commission, which act as the EU competition enforcer, said in a statement.

"The brands covered by the divestment are Kotex (including the Lidie sub-brand), Camelia, and Record", it said.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk